Skip to main content
Equibles

MYSE · Myseum.AI, Inc. · Metrics

Track MYSE — free

Use MYSE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MYSE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.44 -0.04 (-2.70%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year from the date these consolidated financial statements are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$7.69M
Shares
5.20M
Volume · Oct 21 22.14K Avg daily vol (3M) 94.84K

MYSE metrics

75 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.48
Market cap
$7.69M

Price action

20 metrics
Price change (1W)
-10.3%
Price change (30D)
-19.6%
Price change (3M)
-42.9%
Price change (6M)
-57.1%
Price change (YTD)
-13.5%
Price change (1Y)
-47.3%
Trailing year
Price change (5Y)
—
52-week high
$3.81
52-week low
$1.33
Change from 52-week high
-61.2%
Change from 52-week low
+11.3%
Annualized volatility
159.3%
Annualized volatility (3M)
94.5%
Beta
1.5
RSI (14D)
29.5
Price vs SMA 50
-34.0%
Price vs SMA 200
-29.1%
Avg volume (3M)
94,843
Relative volume
0.1
Average dollar volume
$223,916

Company

3 metrics
Sector
Technology
Industry
Software - Application
Shares outstanding
5.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
7,327.5×
reciprocal yield 0.0%
EV / EBITDA
—
EV / EBIT
—
P / sales
15,204.0×
reciprocal yield 0.0%
P / book
1.7
reciprocal yield 57.6%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-74.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6,978.7×
reciprocal yield 0.0%
EV / revenue historical average (5Y)
6,978.7×
reciprocal yield 0.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-1,342,628.7%
Trailing 12 months
Net margin
-1,138,930.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$6.70M
Net income (TTM)
−$5.68M
Trailing 12 months
Diluted EPS (TTM)
$-1.25
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.00
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.50
EBITDA per diluted share (TTM)
$-1.49
Net income per diluted share (TTM)
$-1.23
Operating cash flow per diluted share (TTM)
$-1.02
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$-0.09
Stock compensation per diluted share (TTM)
$0.20
Book value per share
$1.43

Growth

11 metrics
Revenue growth YoY
-52.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$499
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+18.3%
Year over year · more shares
Revenue CAGR (3Y)
-77.2%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-129.9%
Return on assets
-107.4%
Debt / equity
0.0
Current ratio
5.3
EBITDA (TTM)
−$6.66M
Free cash flow (TTM)
—
Quick ratio
5.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$3.93M
Latest balance sheet
Cash & equivalents
$1.87M
Total assets
$5.29M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.55M
Capital expenditures (TTM)
—
R&D (TTM)
−$282,309
SG&A (TTM)
—
Stock compensation (TTM)
$882,761
R&D / revenue
—
Stock compensation / revenue
176,906.0%

Ownership (13F)

9 metrics
13F filers
12
13F filer change QoQ
-5
Institutional ownership
3.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
2.0%
Private-fund adviser ownership
0.0%
Active holders' share change QoQ
+147.9%
Holder tenure
3.7
Price vs estimated holder cost
+22.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.5%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 1.1 days to cover
Days to cover
1.1d
Short-squeeze score
38 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1648960 CUSIP 23816M206 13F (30d) 1 filings 1 filers Visit website Investor relations